Mebendazole as Adjuvant Treatment for Colon Cancer

• Status: Recruiting
• Trial end date: 2028-12-01
• Target enrollment: 0
• Participant gender: All

Summary

mebendazole treating colon cancer

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sherief Abd-Elsalam
• Treatments: Bevacizumab; DMP 777; Mebendazole; Piperazine; Piperazine citrate

Criteria

Inclusion Criteria:

• Colorectal cancer stage 4.

Exclusion Criteria:

• Agranulocytosis

• Pregnancy

• Allergy to mebendazole.